Pharma Times -- Merck & Co has appealed to biotechnology companies in the UK and the rest of Europe to approach it with innovative projects, as the drugs major looks to boost its list of alliances and consequently pipeline.
Pharma Times -- Merck & Co has appealed to biotechnology companies in the UK and the rest of Europe to approach it with innovative projects, as the drugs major looks to boost its list of alliances and consequently pipeline.
